New Evidence on the Association between Prediagnostic Thyroid-Stimulating Hormone Levels and Thyroid Cancer Risk.
作者信息
Kitahara Cari M
机构信息
Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, NCI, NIH, U.S. Department of Health and Human Services, Bethesda, Maryland.
出版信息
Cancer Epidemiol Biomarkers Prev. 2017 Aug;26(8):1163-1164. doi: 10.1158/1055-9965.EPI-17-0329.
Abstract
摘要
相似文献
1
New Evidence on the Association between Prediagnostic Thyroid-Stimulating Hormone Levels and Thyroid Cancer Risk.诊断前促甲状腺激素水平与甲状腺癌风险关联的新证据。
Cancer Epidemiol Biomarkers Prev. 2017 Aug;26(8):1163-1164. doi: 10.1158/1055-9965.EPI-17-0329.
2
Fasting serum glucose, thyroid-stimulating hormone, and thyroid hormones and risk of papillary thyroid cancer: A case-control study.空腹血糖、促甲状腺激素、甲状腺激素与甲状腺乳头状癌风险：一项病例对照研究。
Head Neck. 2019 Jul;41(7):2277-2284. doi: 10.1002/hed.25691. Epub 2019 Feb 13.
3
Thyroid-Stimulating Hormone, Thyroid Hormones, and Risk of Papillary Thyroid Cancer: A Nested Case-Control Study.促甲状腺激素、甲状腺激素与甲状腺乳头状癌风险：一项巢式病例对照研究。
Cancer Epidemiol Biomarkers Prev. 2017 Aug;26(8):1209-1218. doi: 10.1158/1055-9965.EPI-16-0845. Epub 2017 Apr 4.
4
Impaired thyroid hormone sensitivity increases the risk of papillary thyroid cancer and cervical lymph node metastasis.甲状腺激素敏感性受损会增加甲状腺乳头状癌和颈部淋巴结转移的风险。
Endocrine. 2024 Mar;83(3):659-670. doi: 10.1007/s12020-023-03508-2. Epub 2023 Sep 5.
5
Early-pregnancy sex steroid and thyroid function hormones, thyroid autoimmunity, and maternal papillary thyroid cancer incidence in the Finnish Maternity Cohort.早孕期性激素和甲状腺功能激素、甲状腺自身免疫与芬兰母婴队列中母亲甲状腺乳头状癌发病的关系。
Int J Cancer. 2024 Sep 15;155(6):1014-1022. doi: 10.1002/ijc.34974. Epub 2024 May 2.
6
Is thyroid hormone supplementation avoidable for patients with low-risk papillary thyroid cancer after thyroid lobectomy? A two-center observational study.甲状腺叶切除术后低危乳头状甲状腺癌患者是否可避免补充甲状腺激素？一项双中心观察性研究。
Clin Endocrinol (Oxf). 2022 Mar;96(3):413-418. doi: 10.1111/cen.14580. Epub 2021 Aug 16.
7
Sensitivity to thyroid hormone indices are associated with papillary thyroid carcinoma in Chinese patients with thyroid nodules.甲状腺激素指标的敏感性与中国甲状腺结节患者的甲状腺乳头状癌有关。
BMC Endocr Disord. 2023 Jun 1;23(1):126. doi: 10.1186/s12902-023-01381-8.
8
Thyroid hormones in epileptic children receiving carbamazepine and valproic acid.接受卡马西平和丙戊酸治疗的癫痫儿童的甲状腺激素
Pediatr Neurol. 2001 Jul;25(1):43-6. doi: 10.1016/s0887-8994(01)00279-x.
9
Optimal thyrotropin level for low-risk papillary thyroid carcinoma after ultrasound-guided radiofrequency ablation.超声引导下射频消融术后低危甲状腺乳头状癌的最佳促甲状腺激素水平
Int J Hyperthermia. 2023;40(1):2160880. doi: 10.1080/02656736.2022.2160880.
10
Age-based factors modulating the required thyroxine dose to achieve thyrotropin suppression in intermediate-and high-risk papillary thyroid cancer.基于年龄的因素调节甲状腺癌中高危患者达到促甲状腺激素抑制所需的甲状腺素剂量。
Front Endocrinol (Lausanne). 2023 Jun 14;14:1126592. doi: 10.3389/fendo.2023.1126592. eCollection 2023.
引用本文的文献
1
Iodine promotes thyroid cancer development via SPANXA1 through the PI3K/AKT signalling pathway.碘通过SPANXA1经PI3K/AKT信号通路促进甲状腺癌发展。
Oncol Lett. 2019 Jul;18(1):637-644. doi: 10.3892/ol.2019.10391. Epub 2019 May 21.
本文引用的文献
1
Thyroid-Stimulating Hormone, Thyroid Hormones, and Risk of Papillary Thyroid Cancer: A Nested Case-Control Study.促甲状腺激素、甲状腺激素与甲状腺乳头状癌风险：一项巢式病例对照研究。
Cancer Epidemiol Biomarkers Prev. 2017 Aug;26(8):1209-1218. doi: 10.1158/1055-9965.EPI-16-0845. Epub 2017 Apr 4.
2
The changing incidence of thyroid cancer.甲状腺癌发病率的变化
Nat Rev Endocrinol. 2016 Nov;12(11):646-653. doi: 10.1038/nrendo.2016.110. Epub 2016 Jul 15.
3
Thyroid-stimulating hormone, thyroglobulin, and thyroid hormones and risk of differentiated thyroid carcinoma: the EPIC study.促甲状腺激素、甲状腺球蛋白、甲状腺激素与分化型甲状腺癌风险：EPIC 研究。
J Natl Cancer Inst. 2014 Jun;106(6):dju097. doi: 10.1093/jnci/dju097.
4
Thyrotropin and thyroid cancer diagnosis: a systematic review and dose-response meta-analysis.促甲状腺激素与甲状腺癌诊断：系统评价和剂量反应荟萃分析。
J Clin Endocrinol Metab. 2012 Aug;97(8):2682-92. doi: 10.1210/jc.2012-1083. Epub 2012 May 23.
5
Association between benign thyroid and endocrine disorders and subsequent risk of thyroid cancer among 4.5 million U.S. male veterans.美国 450 万男性退伍军人良性甲状腺和内分泌疾病与随后甲状腺癌风险的关系。
J Clin Endocrinol Metab. 2012 Aug;97(8):2661-9. doi: 10.1210/jc.2011-2996. Epub 2012 May 8.
6
Discovery of common variants associated with low TSH levels and thyroid cancer risk.发现与 TSH 水平低和甲状腺癌风险相关的常见变异。
Nat Genet. 2012 Jan 22;44(3):319-22. doi: 10.1038/ng.1046.
7
Autoimmunity in differentiated thyroid cancer: significance and related clinical problems.分化型甲状腺癌中的自身免疫：意义及相关临床问题。
Hormones (Athens). 2010 Apr-Jun;9(2):109-17. doi: 10.14310/horm.2002.1261.
8
Nonradiation risk factors for thyroid cancer in the US Radiologic Technologists Study.美国放射技师研究中的甲状腺癌非放射性危险因素。
Am J Epidemiol. 2010 Jan 15;171(2):242-52. doi: 10.1093/aje/kwp354. Epub 2009 Nov 30.
9
Risk factors for thyroid cancer: an epidemiological review focused on nutritional factors.甲状腺癌的危险因素：一项聚焦于营养因素的流行病学综述
Cancer Causes Control. 2009 Feb;20(1):75-86. doi: 10.1007/s10552-008-9219-5. Epub 2008 Sep 3.
10
Cohort study of thyroid cancer in a San Francisco Bay area population.旧金山湾区人群甲状腺癌队列研究。
Int J Cancer. 2001 Sep 1;93(5):745-50. doi: 10.1002/ijc.1377.
Zotero 插件